Colistin Combined With Tigecycline: A Promising Alternative Strategy to Combat
MCR-1
New Delhi metallo-β-lactamases-5
carbapenem-resistance
carbapenem-resistant Enterobacteriaceae
colistin-resistance
combination therapy
Journal
Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977
Informations de publication
Date de publication:
2019
2019
Historique:
received:
12
09
2019
accepted:
09
12
2019
entrez:
24
1
2020
pubmed:
24
1
2020
medline:
24
1
2020
Statut:
epublish
Résumé
Infections due to carbapenem-resistant NDM-producing
Identifiants
pubmed: 31969868
doi: 10.3389/fmicb.2019.02957
pmc: PMC6960404
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2957Informations de copyright
Copyright © 2020 Zhou, Liu, Zhang, Liao, Sun and Liu.
Références
Arch Microbiol. 1996 Jun;165(6):359-69
pubmed: 8661929
Front Cell Infect Microbiol. 2017 Feb 17;7:37
pubmed: 28261566
Clin Infect Dis. 2012 Aug;55(4):534-42
pubmed: 22573850
Int J Antimicrob Agents. 2018 May;51(5):714-720
pubmed: 29305956
Int J Antimicrob Agents. 2016 Oct;48(4):388-94
pubmed: 27474467
ACS Infect Dis. 2015 Nov 13;1(11):568-575
pubmed: 27525307
Int J Antimicrob Agents. 2016 Sep;48(3):331-6
pubmed: 27449542
Clin Infect Dis. 2003 Feb 15;36(4):462-7
pubmed: 12567304
Nat Commun. 2018 Jan 31;9(1):458
pubmed: 29386620
Nat Protoc. 2008;3(2):163-75
pubmed: 18274517
Clin Infect Dis. 2016 Dec 23;64(5):565-571
pubmed: 28011614
Diagn Microbiol Infect Dis. 2008 Mar;60(3):319-22
pubmed: 17996417
Br J Pharmacol. 2019 Dec;176(23):4548-4557
pubmed: 31376166
Int J Antimicrob Agents. 2016 Dec;48(6):592-597
pubmed: 27793510
J Antimicrob Chemother. 2004 Apr;53(4):592-9
pubmed: 14985271
BMC Infect Dis. 2011 Apr 27;11:109
pubmed: 21521536
Int J Antimicrob Agents. 2010 Feb;35(2):194-9
pubmed: 20006471
J Infect. 2019 May;78(5):364-372
pubmed: 30851289
Nat Microbiol. 2019 Sep;4(9):1457-1464
pubmed: 31235960
J Antimicrob Chemother. 2016 Aug;71(8):2321-5
pubmed: 27334665
Int J Antimicrob Agents. 2016 Nov;48(5):559-563
pubmed: 27670371
J Int Med Res. 2013 Dec;41(6):1830-7
pubmed: 24265334
Int J Antimicrob Agents. 2017 May;49(5):609-616
pubmed: 28315729
Clin Microbiol Infect. 2006 Dec;12(12):1227-30
pubmed: 17121631
Antimicrob Agents Chemother. 2016 Jul 22;60(8):5014-7
pubmed: 27216063
Clin Infect Dis. 2005 Sep 1;41 Suppl 5:S333-40
pubmed: 16080071
J Antimicrob Chemother. 2015 Dec;70(12):3291-7
pubmed: 26318190
Int J Antimicrob Agents. 2012 Mar;39(3):251-4
pubmed: 22154856
Clin Infect Dis. 2016 Nov 1;63(suppl 3):S88-S94
pubmed: 27742639
Lancet Infect Dis. 2016 Mar;16(3):288-9
pubmed: 26842777
Antimicrob Agents Chemother. 2014;58(2):654-63
pubmed: 24080646
Antiviral Res. 1990 Oct-Nov;14(4-5):181-205
pubmed: 2088205
Trends Microbiol. 2018 Sep;26(9):794-808
pubmed: 29525421
World J Emerg Med. 2013;4(3):169-74
pubmed: 25215113
J Microbiol Immunol Infect. 2017 Dec;50(6):931-939
pubmed: 28716360
Antimicrob Agents Chemother. 2011 Dec;55(12):5952-4
pubmed: 21930874
Eur J Clin Pharmacol. 2013 Jul;69(7):1429-36
pubmed: 23508665
Nat Microbiol. 2016 Sep 26;1:16176
pubmed: 27668643
Expert Rev Anti Infect Ther. 2012 Aug;10(8):917-34
pubmed: 23030331
Microbiol Mol Biol Rev. 2001 Jun;65(2):232-60 ; second page, table of contents
pubmed: 11381101
Int J Antimicrob Agents. 2011 Mar;37(3):244-7
pubmed: 21236643
Crit Care. 2014 May 05;18(3):R90
pubmed: 24887101
J Antimicrob Chemother. 2011 Oct;66(10):2295-7
pubmed: 21807739
Lancet Infect Dis. 2016 Mar;16(3):287-8
pubmed: 26842776
J Antimicrob Chemother. 2011 Sep;66(9):1963-71
pubmed: 21685488
J Antimicrob Chemother. 2017 Jun 1;72(6):1723-1730
pubmed: 28333193
Antimicrob Agents Chemother. 2012 Jun;56(6):3441-3
pubmed: 22391543
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29038275
Lancet Infect Dis. 2016 Feb;16(2):161-8
pubmed: 26603172
Lancet Infect Dis. 2018 Apr;18(4):358-360
pubmed: 29456042
Antimicrob Agents Chemother. 2006 Nov;50(11):3701-7
pubmed: 16940069